CancerDrs

Bladder Cancer

Urothelial carcinoma of the bladder. Non-muscle-invasive and muscle-invasive disease both have active trial programs.

79%
5-year relative survival
U.S. average across all stages
198
recruiting trials
Active in the U.S. right now
84,870
new diagnoses / year
You are not alone — roughly 233 people per day
73
median age at diagnosis
Most diagnoses occur in adults over age 50

Source: NCI SEER + ClinicalTrials.gov

Bladder Cancer by the numbers (U.S.)

84,870
Estimated new cases (2025)
17,420
Estimated deaths (2025)
79%
5-year relative survival
73
Median age at diagnosis

Source: NCI SEER Cancer Stat Facts

Bladder Cancer clinical trials →

198 actively recruiting trials across the U.S., with filters by state.

FDA-approved drugs & cost →

Every FDA-approved therapy with bladder cancer in its indications — mechanisms, Medicare spending per drug, manufacturer assistance.

Drug costs overview →

CMS Medicare spending data for 15 major oncology drugs — what patients and Medicare actually pay.

Second opinion for bladder cancer →

Step-by-step for getting a virtual second opinion from a top cancer center.

NCI-designated cancer centers →

All 71 NCI cancer centers with hospital quality data and state browser.

Find a medical oncologist →

Licensed oncologists across every U.S. state, by specialty.

Financial aid resources →

Co-pay relief, drug patient-assistance, transportation, and lodging support.

Patient guides →

How to read a pathology report, questions to ask your oncologist, staging explained.

Also known as

urothelial carcinoma.

For deeper statistics

See the NCI SEER Cancer Stat Facts page: Bladder Cancer on SEER →